natsuko is a prime example on how not to invest. Jumping from one hot counter to another, hoping to earn money from riding the bull's tail. More often than not kena bakar during the process and then cry father cry mother (for more money).
Now this fella go to every glove counters and shill for Dnex, which already at 52-week high and climbing. Shorties are already waiting at Dnex doorstep, waiting for their next move.
I think Stanley has acted quite silly in not wanting to complete the deal with the 30% EPU quota. This is like challenging the policy. Cannot do business in Malaysia if you dont want to comply with policy.
Us: wolf is coming Ukr: ??. Help me money and weapon support. Rus: still under discussion Us: Help you. See first. See got benefits for help you or not.
No matter how terrible also will have hundred millions of profit, better than 90% of bursa counters. The next deadlier covid strain will be born or maybe born already. Glove business huat huat huat.
Sure you can add more and cheaper coming soon. Maybe you can even get a 10% discount cheaper price by next month, nobody knows. What I see is no fund wants to buy yet. Or maybe no fund buy at current price, but a more cheaper price later. If only Supermax worth it.
The world is going back to normal soon , all will open boarder follow western countries since 3 doses vaccine prevent severe symtoms , if u still dreaming in glove 2020 glorious day u might lose further 50% capital if glove company starts seeing net loss or only get double digit million qr net profit !
Yes.. Bad result is within expectation. Same goes to share price moving low and keep hitting new low but would not rebound much. Many expecting something bad is coming too.
If Supermax QR profits release next week almost similar to Kossan and Harta around 200 millions it will be a big surprise since US and Canada CBP ban still on going since October
FRANKFURT: The world is becoming "better prepared" to deal with future variants of the coronavirus, the CEO and co-founder of German vaccine-maker BioNTech told AFP Thursday, as the company works on an Omicron-specific shot.
"We will have to get used to the fact that we will have to live with the virus for the next 10 years," said Ugur Sahin, whose company developed the first mRNA vaccine against the virus with US pharma giant Pfizer.
New virus variants were inevitable "because the virus will mutate further", he said, potentially leading to new flare-ups in cases.
XAU/USD Current price: $1,867.35 Demand for safe-haven assets has resumed amid concerns over a war in Europe. Government bond yields fell to fresh weekly lows amid a run to safety. XAU/USD has room to extend its advance, despite technical overbought readings.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
bang_miskin
1,059 posts
Posted by bang_miskin > 2022-02-15 13:37 | Report Abuse
natsuko is a prime example on how not to invest. Jumping from one hot counter to another, hoping to earn money from riding the bull's tail. More often than not kena bakar during the process and then cry father cry mother (for more money).
Now this fella go to every glove counters and shill for Dnex, which already at 52-week high and climbing. Shorties are already waiting at Dnex doorstep, waiting for their next move.